ArticleVaccines2022

Induction of Broadly Cross-Reactive Antibodies by Displaying Receptor Binding Domains of SARS-CoV-2 on Virus-like Particles.

Xinyue Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.